Our research reveals that liver fibrosis in patients with NAFLD (MASLD) is a key independent predictor of future adverse cardiovascular events, cardiovascular mortality, and all-cause mortality. These findings highlight the critical need for early detection and intervention in this patient group. #NAFLD #LiverHealth #CardiovascularRisk #MedicalResearch
@AmitPursnaniMD @kaveh_med @basilenjei @DrRichard_orji